Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Entera Bio (ENTX) Current Leases (2019 - 2025)

Entera Bio has reported Current Leases over the past 7 years, most recently at $230000.0 for Q4 2025.

  • For the quarter ending Q4 2025, Current Leases rose 35.29% year-over-year to $230000.0, compared with a TTM value of $230000.0 through Dec 2025, up 35.29%, and an annual FY2025 reading of $230000.0, up 35.29% over the prior year.
  • Current Leases came in at $230000.0 for Q4 2025, up from $170000.0 in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $230000.0 in Q4 2025 to a low of $48000.0 in Q1 2023.
  • Median Current Leases over the past 5 years was $165500.0 (2024), compared with a mean of $155700.0.
  • The sharpest move saw Current Leases crashed 66.2% in 2023, then skyrocketed 218.75% in 2024.
  • Over 5 years, Current Leases stood at $179000.0 in 2021, then tumbled by 49.16% to $91000.0 in 2022, then skyrocketed by 47.25% to $134000.0 in 2023, then rose by 26.87% to $170000.0 in 2024, then soared by 35.29% to $230000.0 in 2025.
  • Per Business Quant, the three most recent readings for ENTX's Current Leases are $230000.0 (Q4 2025), $170000.0 (Q3 2025), and $194000.0 (Q2 2025).